Mei, Y., Chen, M. M., Liang, H., & Ma, L. (2021). A four-gene signature predicts survival and anti-CTLA4 immunotherapeutic responses based on immune classification of melanoma. Nature Portfolio.
Chicago Style (17th ed.) CitationMei, Ying, Mei-Ju May Chen, Han Liang, and Li Ma. A Four-gene Signature Predicts Survival and Anti-CTLA4 Immunotherapeutic Responses Based on Immune Classification of Melanoma. Nature Portfolio, 2021.
MLA (8th ed.) CitationMei, Ying, et al. A Four-gene Signature Predicts Survival and Anti-CTLA4 Immunotherapeutic Responses Based on Immune Classification of Melanoma. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.